Our story
- About us
- Latest
- Centres
Our science
- Mission
  - Discover
  - Develop
  - Deliver
- Approaches
- Explore by
Our people
- Researchers
- Governance
- Latest
  
  Feb 19, 2026
  
  First Group Leaders announced for new dedicated Parkinson's Research Centre
  
  In 2025, the UK DRI partnered with Parkinson’s UK to launch a new £10m research...
  Learn more First Group Leaders announced for new dedicated Parkinson's Research Centre
Our partners
- Partnerships
- Initiatives
- Latest
  
  Jan 01, 2024
  
  Why partner with the UK DRI?
  
  The UK DRI is central to a rich and connected dementia research ecosystem, and we...
  Learn more Why partner with the UK DRI?
Careers
- Join us
  - Vacancies
  - Centres
- Latest
  
  Jan 01, 2024
  
  Why join the UK DRI?
  
  By joining the UK DRI you’ll belong to a team of world-class researchers, technical specialists...
  Learn more Why join the UK DRI?
Public Information
- Information
- Dementias
- Movement conditions

Journal of neurology, neurosurgery, and psychiatry

Published Apr 17, 2026

Comparing amyloid immunotherapy with cholinesterase inhibitors for Alzheimer's disease

Authors

Christopher R S Belder, Nick C Fox

Read More

Abstract

J Neurol Neurosurg Psychiatry. 2026 Apr 17:jnnp-2026-338722. doi: 10.1136/jnnp-2026-338722. Online ahead of print.

NO ABSTRACT

PMID:41997746 | DOI:10.1136/jnnp-2026-338722